CME Group (NASDAQ:CME) – Research analysts at Jefferies Group issued their Q2 2018 earnings per share estimates for shares of CME Group in a research report issued on Tuesday, April 10th. Jefferies Group analyst D. Fannon expects that the financial services provider will earn $1.64 per share for the quarter. Jefferies Group also issued estimates for CME Group’s Q3 2018 earnings at $1.60 EPS, Q4 2018 earnings at $1.57 EPS, FY2018 earnings at $6.65 EPS and FY2019 earnings at $6.87 EPS.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.14 earnings per share.
Shares of CME Group stock opened at $164.21 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03. The stock has a market capitalization of $54,890.48, a price-to-earnings ratio of 33.88, a PEG ratio of 2.21 and a beta of 0.56. CME Group has a 52-week low of $114.82 and a 52-week high of $171.71.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. ARK Investment Management LLC bought a new stake in CME Group during the fourth quarter valued at approximately $120,000. Valeo Financial Advisors LLC bought a new stake in CME Group during the third quarter valued at approximately $124,000. AlphaOne Investment Services LLC bought a new stake in CME Group during the fourth quarter valued at approximately $146,000. Mosaic Family Wealth LLC bought a new stake in CME Group during the fourth quarter valued at approximately $146,000. Finally, Truewealth LLC bought a new stake in CME Group during the fourth quarter valued at approximately $157,000. Institutional investors own 83.12% of the company’s stock.
In related news, insider Derek Sammann sold 2,400 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $161.66, for a total transaction of $387,984.00. Following the completion of the sale, the insider now directly owns 40,153 shares in the company, valued at $6,491,133.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Leo Melamed sold 7,300 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $155.78, for a total transaction of $1,137,194.00. Following the sale, the director now owns 10,537 shares of the company’s stock, valued at $1,641,453.86. The disclosure for this sale can be found here. Insiders have sold 35,699 shares of company stock valued at $5,532,362 over the last 90 days. 0.57% of the stock is currently owned by company insiders.
The firm also recently announced a quarterly dividend, which was paid on Monday, March 26th. Investors of record on Friday, March 9th were given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 1.71%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date was Thursday, March 8th. CME Group’s payout ratio is 58.70%.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.